Human distribution and release of a putative new gut hormone, peptide YY
- PMID: 3840109
- DOI: 10.1016/0016-5085(85)90211-2
Human distribution and release of a putative new gut hormone, peptide YY
Abstract
A radioimmunoassay has been developed for the new intestinal hormonal peptide tyrosine tyrosine [peptide YY (PYY)]. Peptide YY concentrations were measured in separated layers of the human gastrointestinal tract, where PYY was found exclusively in the mucosal epithelium which contained the endocrine cells. Peptide YY was found throughout the small intestine, in very low concentrations (5 pmol/g) in duodenum (6 pmol/g) and jejunum (5 pmol/g), but in higher concentrations in the terminal ileum (84 pmol/g). High concentrations were found throughout the colon (ascending 82 pmol/g, sigmoid 196 pmol/g), being maximum in the rectum (480 pmol/g). The major molecular form of PYY-like immunoreactivity in human intestine appeared to be identical to pure porcine hormone, both as judged by gel permeation chromatography and by reverse-phase high-pressure liquid chromatography. Basal plasma concentrations of PYY were low but rose in response to food, remaining elevated for several hours postprandially. The known potent biologic actions of PYY, its high concentrations in gut endocrine cells, and its release into the circulation after a normal meal suggest that this peptide may function physiologically as a circulating gut hormone.
Similar articles
-
Distribution and postprandial release of porcine peptide YY.J Endocrinol. 1987 Apr;113(1):11-4. doi: 10.1677/joe.0.1130011. J Endocrinol. 1987. PMID: 3585220
-
Peptide YY-like immunoreactivity in normal colon mucosa, muscle layer and adenocarcinoma.Jpn J Med. 1987 May;26(2):184-8. doi: 10.2169/internalmedicine1962.26.184. Jpn J Med. 1987. PMID: 3626157
-
Fractionated irradiation alters enteric neuroendocrine products.Dig Dis Sci. 1995 Aug;40(8):1691-702. doi: 10.1007/BF02212690. Dig Dis Sci. 1995. PMID: 7544259
-
Ontogeny of endocrine cells in porcine gut and pancreas. An immunocytochemical study.Gastroenterology. 1983 Dec;85(6):1359-72. Gastroenterology. 1983. PMID: 6138293 Review.
-
The therapeutic potential of gut hormone peptide YY3-36 in the treatment of obesity.Expert Opin Investig Drugs. 2005 May;14(5):647-53. doi: 10.1517/13543784.14.5.647. Expert Opin Investig Drugs. 2005. PMID: 15926870 Review.
Cited by
-
Bariatric surgery and the central nervous system.Obes Surg. 2012 Jun;22(6):967-78. doi: 10.1007/s11695-012-0649-5. Obes Surg. 2012. PMID: 22488684 Review.
-
Gut hormones in adaptation.Gut. 1987;28 Suppl(Suppl):31-5. doi: 10.1136/gut.28.suppl.31. Gut. 1987. PMID: 3692318 Free PMC article.
-
Rectal taurocholate increases L cell and insulin secretion, and decreases blood glucose and food intake in obese type 2 diabetic volunteers.Diabetologia. 2012 Sep;55(9):2343-7. doi: 10.1007/s00125-012-2593-2. Epub 2012 Jun 14. Diabetologia. 2012. PMID: 22696033
-
Terbutaline, a beta 2-adrenoreceptor agonist, inhibits gastric acid secretion and stimulates release of peptide YY and gastric inhibitory polypeptide in dogs.Dig Dis Sci. 1990 Apr;35(4):453-7. doi: 10.1007/BF01536919. Dig Dis Sci. 1990. PMID: 2156661
-
Variants in the 5' region of the neuropeptide Y receptor Y2 gene (NPY2R) are associated with obesity in 5,971 white subjects.Diabetologia. 2006 Nov;49(11):2653-8. doi: 10.1007/s00125-006-0425-y. Epub 2006 Sep 22. Diabetologia. 2006. PMID: 17019604
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources